Aldeyra Therapeutics (ALDX) Earnings Date & Reports

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ALDX is expected to report earnings to fall 9.63% to -24 cents per share on May 01

Aldeyra Therapeutics ALDX Stock Earnings Reports

Q1'25

Est.

$-0.24

Q4'24

Missed

by $0.03

Q3'24

Missed

by $0.01

Q2'24

Missed

by $0.02

Q1'24

Missed

by $0.01

The last earnings report on March 06 showed earnings per share of -27 cents, missing the estimate of -23 cents. With 3.70M shares outstanding, the current market capitalization sits at 84.79M.

View a ticker or compare two or three

Compare

ALDX